Sentynl Therapeutics
Pre-clinicalSentynl Therapeutics, Inc. is a US-based specialty pharmaceutical company dedicated to improving patient care through innovative therapeutics.
Founded
2016
Focus
Small Molecules
About
Sentynl Therapeutics, Inc. is a US-based specialty pharmaceutical company dedicated to improving patient care through innovative therapeutics.
Funding History
2Total raised: $210M
Series B$150MHBM Healthcare InvestmentsJan 15, 2022
Series A$60MHBM Healthcare InvestmentsJul 15, 2020
Company Info
TypePrivate
Founded2016
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile